Powered by

gammaCore„¢ Now Available Through U.S. Federal Government's Federal Supply Schedule (FSS)

Jan 02, 2019 - GlobeNewswire

BASKING RIDGE, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced its non-invasive vagus nerve stimulation (nVNS) therapy, gammaCoreTM, has been awarded a five-year Federal Supply Schedule Medical Equipment and Supply contract which will make gammaCore available in January to the over 21 million patients managed within the Department of Veteran's Affairs, Department of Defense, Bureau of Prisons, Indian H...